Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS® AmpliPrep/COBAS® TaqMan® system

Journal of Clinical Virology

Volumn 38, Issue 4, 2007, Pages 304-312

  Schumacher, Wolfram ^a   Frick, Edmund ^a   Kauselmann, Mirko ^a   Maier Hoyle, Viola ^a   van der Vliet, Reinier ^a   Babiel, Reiner ^a  

^a ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Automated RNA extraction; HIV 1 viral load quantification; Real time PCR; Therapy monitoring

Indexed keywords

VIRUS RNA;

ARTICLE; AUTOMATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; VIRUS DETECTION;

ANALYSIS OF VARIANCE; HIV INFECTIONS; HIV-1; HUMANS; PLASMA; POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 33947141044     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2006.12.022     Document Type: Article

References (37)

1. Albert J., Abrahamsson B., Nagy K., Aurelius E., Gaines H., Nystrom G., et al. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 4 2 (1990) 107-112
2. Barre-Sinoussi F., Chermann J.C., Rey F., Nugeyre M.T., Chamaret S., Gruest J., et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220 (1983) 868-871
3. ® HIV-1 MONITOR Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples. J Clin Virol 33 (2005) 43-51
4. ® HIV-1 Monitor test (manual specimen preparation). J Clin Virol 25 Suppl 3 (2002) S103-S107
5. Collins M.L., Irvine B., Tyner D., Fine E., Zayati C., Chang C., et al. A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml. Nucleic Acids Res 25 (1997) 2979-2984
6. Coombs R.W., Welles S.L., Hooper C., Reichelderfer P.S., D'Aquila R.T., Japour A.J., et al. Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working Groups. J Infect Dis 174 (1996) 704-712
7. Curran J.W., Jaffe H.W., Hardy A.M., Morgan W.M., Selik R.M., and Dondero T.J. Epidemiology of HIV infection and AIDS in the United States. Science 239 4840 (1988) 610-616
8. Daar E.S., Moudgil T., Meyer R.D., and Ho D.D. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 324 (1991) 961-964
9. Deeks S.G., Coleman R.L., White R., Pachl C., Schambelan M., Chernoff D.N., et al. Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between days. J Infect Dis 176 (1997) 514-517
10. ® MONITOR version 1.5. J Clin Microbiol 38 (2000) 1113-1120
11. Fauci A.S., Schnittman S.M., Poli G., Koenig S., and Pantaleo G. HIH conference: immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med 114 (1991) 678-693
12. Gaines H., von Sydow M.A., von Stedingk L.V., Biberfeld G., Bottiger B., Hansson L.O., et al. Immunological changes in primary HIV-1 infection. AIDS 4 (1990) 995-999
13. Gürtler L. J Virol 68 (1994) 1581-1585
14. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. May 4, 2006. http://www.aidsinfo.nih.gov/guidlines/.
15. Higuchi R., Dollinger G., Walsh P.S., and Griffith R. Simultaneous amplification and detection of specific DNA sequences. Bio/Technology 10 (1992) 413-417
16. ® system. J Clin Virol 35 (2006) 373-380
17. Holmes H., Davis C., Heath A., Hewlett I., and Lelie N. An international collaborative study to establish the 1st international standard for HIV-1 RNA for use in nucleic acid-based techniques. J Virol Meth 92 (2001) 141-150
18. Holodniy M. In: Baker R, editor. Critical issues in the treatment and management of HIV infection. Review of HIV-1 viral load testing; 2005. www.HIVandHepatitis.com.
19. Ioannidis J.P., Tatsioni A., Abrams E.J., Bulterys M., Coombs R.W., Goedert J.J., et al. Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis. AIDS 18 (2004) 99-108
20. Kandathil A.J., Ramalingam S., Kannangai R., David S., and Sridharan G. Molecular epidemiology of HIV. Indian J Med Res 121 (2005) 333-344
21. Kassutto S., and Rosenberg E.S. Primary HIV type 1 infection. Clin Infect Dis 38 (2004) 1447-1453
22. Kwok S., and Sninsky J.J. PCR detection of human immunodeficiency virus type 1 proviral DNA sequences. In: Persing D.H., Smith T.F., Smith F.C., Tenover T.J., and White T.J. (Eds). Diagnostic molecular biology: principles and applications (1993), ASM Press, Washington, DC
23. Mellors J.W., Munoz A., Giorgi J.V., Margolick J.B., Tassoni C.J., Gupta P., et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 126 (1997) 946-954
24. ® MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 38 (2000) 4034-4041
25. Phillips A., and CASCADE Collaboration. Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era. AIDS 18 (2004) 51-58
26. Phillips A.N., et al. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA 286 (2001) 2560-2567
27. Postic B., Horvath J.A., and Talwani R. Antiviral treatment of human immunodeficiency virus infection: update for 2003. J S C Med Assoc 99 (2003) 148-153
28. Popovic M., Sarngadharan M.G., Read E., and Gallo R.C. Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224 (1984) 497-500
29. Quinn T.C., and Overbaugh J. HIV/AIDS in women: an expanding epidemic. Science 308 (2005) 1582-1583
30. Raboud J.M., Montaner J.S., Conway B., Rae S., Reiss P., Vella S., et al. Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy. AIDS 12 (1998) 1619-1624
31. Rosenberg E.S., Altfeld M., Poon S.H., Phillips M.N., Wilkes B.M., Eldridge R.L., et al. Immune control of HIV-1 after early treatment of acute infection. Nature 407 (2000) 523-526
32. ® system. J Clin Virol; accepted for publication.
33. ® HIV-1 RNA 3.0, and NucliSens HIV-1 QT. J Clin Microbiol 43 (2005) 3860-3868
34. ® HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0. J Clin Microbiol 39 (2001) 862-870
35. Thomson M.M., and Najera R. Molecular epidemiology of HIV-1 variants in the global AIDS pandemic: an update. AIDS Rev 7 (2005) 210-224
36. Valentine-Thon E. Quality control in nucleic acid testing-where do we stand?. J Clin Virol 25 (2002) S13-S21
37. Welles S.L., Jackson J.B., Yen-Lieberman B., Demeter L., Japour A.J., Smeaton L.M., et al. Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 Team. J Infect Dis 174 (1996) 696-703